Clinical Trial Update: CorEvitas Inflammatory Bowel Disease (IBD) Registry

View source ↗

Summary

CorEvitas is enrolling by invitation participants in an inflammatory bowel disease (IBD) registry to collect real-world data on IBD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Snippet

Sponsor: CorEvitas | Conditions: Inflammatory Bowel Diseases | Status: ENROLLING_BY_INVITATION